戻る Agenda
Globalization of Medical Communications/Medical Science Liaisons: A Comparison of Guidance and Practice Differences
Session Chair(s)
Thomas M. Gesell, PHARMD
Medical Information Domain Lead
Envision Pharma Group, United States
Provision of medical communication and medical liaison services within biopharmaceutical companies have existed in one form or another for about 50 years. Over the years, these services have been introduced to countries areas across the globe. With popularity comes the potential for regulation. This session will review some of the different types of medical communication and medical liaison models, review related regulatory guidelines in place, and discuss the implications for the globalization of medical communications and medical liaisons.
Learning Objective : Describe the various models used to provide medical communication, information, and liaison services; List the similarities and differences between regulatory guidelines worldwide covering medical communications and medical liaisons; Assess existing corporate policies and procedures to determine if action is needed to meet regulatory expectations.
Speaker(s)
DIfferences in the Practice of Medical Information Worldwide
Dannis Chang, PHARMD
Genentech, Inc., United States
Director, Hematology Medical Information Team Lead
Regulations and Guidelines Affecting Medical Publications
Thomas M. Gesell, PHARMD
Envision Pharma Group, United States
Medical Information Domain Lead
Medical Science Liaison Practice Differences Globally
Donna A. Holder, PHARMD
Daiichi Sankyo, Inc., United States
Former Head, Global Medical Digital Strategy & Innovation